AstraZeneca Pharma India Dividends and Buybacks
Dividend criteria checks 2/6
AstraZeneca Pharma India is a dividend paying company with a current yield of 0.38% that is well covered by earnings.
Key information
0.4%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 32.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹24.000 |
| Payout ratio | 37% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 506820 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 506820's dividend payments have increased, but the company has only paid a dividend for 5 years.
Dividend Yield vs Market
| AstraZeneca Pharma India Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (506820) | 0.4% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.2% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (506820) (up to 3 years) | n/a |
Notable Dividend: 506820's dividend (0.38%) is higher than the bottom 25% of dividend payers in the Indian market (0.25%).
High Dividend: 506820's dividend (0.38%) is low compared to the top 25% of dividend payers in the Indian market (1.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (37.1%), 506820's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (721.2%), 506820's dividend payments are not well covered by cash flows.